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Background: Physical symptoms are common in pregnancy and are predominantly associated with normal
physiological changes. These symptoms have a social and economic cost, leading to absenteeism from work and
additional medical interventions. There is currently no simple method for identifying common pregnancy related
problems in the antenatal period. A validated tool, for use by pregnancy care providers would be useful. The aim of
this study was to develop and validate a Pregnancy Symptoms Inventory for use by health professionals.
Methods: A list of symptoms was generated via expert consultation with health professionals. Focus groups were
conducted with pregnant women. The inventory was tested for face validity and piloted for readability and
comprehension. For test-re-test reliability, the tool was administered to the same women 2 to 3 days apart. Finally,
midwives trialled the inventory for 1 month and rated its usefulness on a 10cm visual analogue scale (VAS).
Results: A 41-item Likert inventory assessing how often symptoms occurred and what effect they had, was
developed. Individual item test re-test reliability was between .51 to 1, the majority (34 items) scoring ≥0.70. The
top four “often” reported symptoms were urinary frequency (52.2%), tiredness (45.5%), poor sleep (27.5%) and back
pain (19.5%). Among the women surveyed, 16.2% claimed to sometimes or often be incontinent. Referrals to the
incontinence nurse increased > 8 fold during the study period.
Conclusions: The PSI provides a comprehensive inventory of pregnancy related symptoms, with a mechanism for
assessing their effect on function. It was robustly developed, with good test re-test reliability, face validity,
comprehension and readability. This provides a validated tool for assessing the impact of interventions in
pregnancy.
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Physical symptoms are common in pregnancy and are
predominantly associated with normal physiological
changes that occur during this time. Much of the litera-
ture reports on one or two specific symptoms but does
not examine the range of potential symptoms possible
during this time [1,2]. The need for such an instrument
became apparent when designing our pregnancy inter-
vention study [3]. Lifestyle and other interventions dur-
ing pregnancy have the potential to alter the frequency
and severity of the full range of pregnancy symptoms,
such as nausea, back pain, incontinence, quality of sleep,
mood or libido. We identified that there is no validated* Correspondence: n.byrne@qut.edu.au
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reproduction in any medium, provided the orway of assessing the impact of pregnancy interventions
on the wide range of pregnancy symptoms that women
experience. Therefore, in this study we outline our ap-
proach to the development and testing of a valid and
robust tool to assess pregnancy symptoms.
A review of the available literature identified a variety
of pregnancy symptoms. Thirty-eight discrete symptoms
have been described [4], with five being reported most
frequently. These are: frequency of micturition (passing
urine), fatigue, pelvic pressure, insomnia and lower back-
ache. Although many studies have investigated a small
number of pregnancy symptoms [5-7] such symptoms
are not always experienced in isolation. However, the
interaction of symptoms, such as back and pelvic pain
causing sleep disturbance or sleep disturbance causing
fatigue are not well explored. Psychosocial variables alsol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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symptoms [8]. Many symptom specific instruments exist
such as the McGill Nausea Questionnaire [9], The Fa-
tigue System Checklist (FSC) [10], Roland-Morris Dis-
ability Questionnaire [11], ICIQ-SF (International
Consultation on Incontinence Questionnaire Short
Form) [12] and the Epworth Sleepiness Scale (ESS) [13].
While these instruments may be helpful in identifying
particular symptoms they do not allow the examination
of all potential symptoms and it is onerous to ask
patients to complete multiple questionnaires.
If inventories are to be useful, they should undergo the
same rigorous reliability and validity checks as other
instruments prior to implementation. The aim of the
project was to develop and validate a Pregnancy
Symptoms Inventory (PSI) as a validated research tool
which could be used to assess a range of pregnancy
symptoms, and determine the impact those symptoms
have on quality of life.Methods and results
Development
This study was conducted at The Royal Brisbane and
Women’s Hospital (RBWH), a large tertiary referral hos-
pital. Approximately 5000 pregnant women per yearFigure 1 Framework for the development and testing of the PSI.attend the Maternity Outpatient Department (MOPD).
A mixed methods design was used; Figure 1 shows the
framework for the development and testing of the in-
strument. Inventory development and testing included
the use of interviews, surveys and focus group methods.
Participants were medical and midwifery staff employed
by RBWH who assisted in the development of the inven-
tory and pregnant women who were involved in its re-
finement and testing. Due to the use of mixed methods
in this study, strategies used for data analysis are
reported by phase. All quantitative data was analysed
using the statistical package SPSS version 16. Ethics ap-
proval was granted by the RBWH ethics committee.Phase 1 (Expert consultation)
A group of seven health professionals (doctors and mid-
wives) working in the MOPD were interviewed and asked
to name all the commonly occurring symptoms of preg-
nancy reported by patients. The symptoms described by
each person were kept in a log, to be reviewed and
categorized after all the experts had been interviewed.Results During this phase 40 items were produced. The
items mentioned most frequently were nausea, tiredness
and sore breasts.
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Pregnant women who were able to provide written
informed consent and who had booked in to the MOPD
for their obstetric care were included.
Focus groups consisted of three groups of 5–6 preg-
nant participants (Group 1 first trimester up to 12 weeks
gestation; Group 2 second trimester 12 to 28 weeks ges-
tation Group 3 third trimester 28 to 40 weeks gestation).
The groups were divided by trimester as some symptoms
such as nausea are more prevalent in the first trimester
whilst back pain and sleeping problems are more preva-
lent in the last trimester. The conversation was audio
taped and transcribed verbatim for analysis. The
women’s terminology formed a basis for the wording of
the items to ensure symptoms were clearly understood.
Results Twenty symptoms were mentioned in focus
groups, nineteen of which had also been mentioned by
the experts; the additional item identified in the focus
group sessions was vivid dreams. A 41- item Likert scale
inventory was formulated via expert consultation and
focus groups.
Initial validation
Responses from interviews with professionals and focus
groups interviews were combined to develop the
Pregnancy Symptoms Inventory (PSI). Items were
categorized by body part or system using terminology
which is understood by lay people e.g. skin/hair, aches
and pains, sleep etc.
The reliability, validity and usefulness of the inventory
were tested in a number of ways.
Face validity
Initially, the entire inventory was reviewed by experts to
test face validity. Two groups of 5–9 midwives were
asked to comment and give feedback on the symptoms
listed, language used and the positioning of symptoms
on the inventory. All responses from the midwives were
noted so that adjustments could be made to better clar-
ify the inventory.
The tool was designed to be easily read and under-
stood and was limited to one 2-sided page so it was
quick and easy to fill out. The format allowed for preg-
nant women to add additional symptoms and the mid-
wives to add comments and record their actions on the
second page.
The Inventory was then piloted on a group of ten
pregnant women of mixed ethnicity to test readability
and comprehension.
Results Three terms were not understood: Chloasma,
Palpitations and Vaginal Varicose Vein. These wordswere changed to “Brownish marks on face”, “Heart
Palpitations” and “Painful Veins in Vagina”.
Test re-test
The Inventory was completed by 20 women twice, 2–3
days apart to assess for test-re-test reliability. The first
group of 20 women completed the first questionnaire at
MOPD and the second test was completed at home 2–3
days later. A second group of 20 women were sent their
first questionnaire to complete at home before a planned
visit and were then asked to repeat the inventory while
waiting for their planned appointment.
This was done to overcome a potential bias that
suggests that answers may vary, depending on the envir-
onment in which the survey is administered [14].
Results The test re test reliability was between .51 to 1,
the majority (34 items) scoring ≥0.70.
Usefulness
MOPD Midwives were educated about the use of the
PSI at their routine lunch meetings and on a one-on-one
basis. Women attending a follow up visit were asked to
fill in the PSI and hand it to their midwife to peruse and
assess. Any problems could be discussed and referred if
necessary to other HCPs. Midwives used the PSI for one
month and recorded any referrals on the form. After the
one month trial had ended the midwives were asked to
rate usefulness of the inventory (which was anonymous)
on a10cm visual analogue scale. The scale ranged from
“Not useful at all” to “Very useful”. After rating the use-
fulness quantitatively, midwives were also asked if using
the instrument had prompted them to act or refer the
woman. They were also asked to comment on any other
aspect of the inventory using an open-ended format.
Because midwives responses to usefulness of the in-
ventory on the 10 cm visual analogue scale were not nor-
mally distributed results were analysed using the median
and range. Comments on the usefulness of the inventory
were reported verbatim.
Practical use (Administration of the inventory)
Women attending the MOPD were asked to list any
symptoms that had occurred in the previous month and
rate them on a 4-point Likert scale according to fre-
quency “never”, “rarely”, “sometimes”, “often”. They were
then asked to rate using a 3-point Likert scale, how the
symptom affected their activities of daily living as “not
limited at all”, “limited a little” or “limited a lot”. See
Figure 2. The women filled in their height, weight and
number of weeks pregnant at the top of the inventory.
The inventory was distributed when women presented
at the clinic. Women completed the inventory while they
waited, which took 5–7 minutes. This then enabled the
Figure 2 Pregnancy symptoms inventory.
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problems and make a comment in the “Midwife action”,
“Referral” (please specify) or “comment sections” as to
what actions, if any, she had taken.
Frequencies were determined by the number of those
women experiencing a particular symptom in the previ-
ous month. Demographic data and incidence and sever-
ity of each of the symptoms were calculated using
means and standard deviations (SD) for continuous data
(e.g. age, gestation).
Results The inventory was given to 211 women
attending routine midwifery appointments for antenatal
care. Responses were received for all 211 women. The
mean age was 28.9 years (SD 6.16; range 15 – 44 years).
The mean gestation was 23.06 weeks (SD 7.46; range
12–42 weeks). None of the women surveyed were in the
first trimester of their pregnancy. This was because
women do not present to MOPD for their first visit until
18 to 20 weeks unless they have a specific medical need
and are then seen by specialist doctors not midwives for
these visits. The majority (153) were in their middle tri-
mester (≥12–28 weeks) and 52 were in their third tri-
mester (≥28–42 weeks). The mean Body Mass Index
(BMI) for respondents was 26.8 (SD 5.89).
Midwives trialled the inventory for 1 month and rated
its usefulness on a 10 cm visual analogue scale (VAS).
The majority of midwives (7 out of 10) rated the use-
fulness at >7 and 4 rated it 10 out of 10. The median
VAS score was 8.4 (range .9 to 10). Midwives found that
the PSI alerted them to significant symptoms, and after
further exploration, this prompted a referral for a spe-
cific need. Comments indicated that the tool was gener-
ally well accepted and that it had the potential for
improving practice.
To assess outcome validity of the PSI, we assessed
whether this triggered midwives to make referrals
regarding symptoms identified. As a result, 35 women
were referred to a physiotherapist; 13 women were re-
ferred to the continence nurse; eleven were referred to
the mental health nurse. The continence nurse is the
only specialist who keeps accurate records of all referralsFigure 3 Incontinence referrals from maternity outpatients.she receives from the MOPD. Consequently, she was
able to provide a snap shot of referrals made during the
12-month period in which the trial was conducted. The
trial of the inventory ran from March 3rd 2008 to 9th
April 2008 in the MOPD. As can be seen in Figure 3,
there was a notable increase in the number of referrals
to the continence nurse in the month of March 2008
(from an average of 1.8/month for the year up to 17
referrals in March) when the pregnancy symptoms in-
ventory was being trialled. This represents more than an
eight-fold increase in the number of referrals. The effect
of the inventory on referrals is further demonstrated by a
return to normal referral patterns once the trial finished.
The top four “often” reported symptoms were urinary
frequency, tiredness, poor sleep and back pain, as
outlined in Table 1. These were similar to the top four
symptoms that women described as “Limit a Lot” their
activities of daily living (ADLs); these were back pain,
tiredness, poor sleep, and nausea. The total number
responding to questions on “Limit” is less as only those
who had experienced that symptom were required to
give an answer. Whilst some of the symptoms had oc-
curred ‘often’ a number of symptoms reported less fre-
quently had the potential to adversely affect the women’s
ADLs. For example, incontinence was reported to occur
“often” by only eight women. However, 34 reported it
occurred sometimes or often and 16 said that this
affected their ADLs. Similarly, Feeling depressed “often”
was reported infrequently. However many more women
said depression affected their ADLs. Poor sleep was
reported by 58 women as occurring often however 96
women said that poor sleep affected their ADLs. Table 2
contains full details.
Discussion
Compared with instruments measuring discrete symptoms,
our comprehensive pregnancy symptoms inventory
provides a useful way of assessing the range of pregnancy
symptoms, and determining the impact those symptoms
have on quality of life. Women found it simple to complete
and midwives confirmed its usefulness.
The PSI was developed within a robust framework,
addressing face validity, test-retest reliability, outcome
validity and practical use. We believe we have developed
a tool which allows the assessment of the number and
severity of pregnancy symptoms women experience.
We designed this tool to fill a gap we identified while
conducting a randomized clinical trial [3]. We could not
identify any brief comprehensive assessment tool to
examine the vast range of pregnancy related symptoms
in their entirety, including an assessment of the effect
these symptoms have on daily life. Our tool assesses the
full spectrum of pregnancy symptoms, and provides a
way of comparing the burden of pregnancy symptoms
Table 1 Prevalence of self-reported pregnancy symptoms reported often or sometimes
Frequency N = Valid responses Often Sometimes Total prevalence
Urinary Frequency 209 52.20% 33% 85.20%
Tiredness 209 45.50% 41.50% 87%
Poor Sleep 211 27.50% 35.05% 62.55%
Back Pain 210 19.50% 40.50% 60.00%
Vaginal Discharge 205 17.60% 32.20% 49.80%
Forgetfulness 198 15.70% 39.90% 55.60%
Headache 200 14.50% 36% 50.50%
Vivid Dreams 201 13.90% 27.40% 41.30%
Taste Smell Changes 197 13.70% 20.30% 34.00%
Change in Nipples 196 13.30% 25% 38.80%
Nausea 207 12.60% 21.70% 34.30%
Change in Libido 197 11.20% 32% 43.20%
Hip Pelvic Pain 199 10.60% 23.10% 33.70%
Constipation 207 10.10% 23.10% 33.20%
Food Cravings 208 9.10% 28.40% 37.50%
Reflux 203 8.90% 20.70% 29.60%
Leg Cramps 210 8.60% 22.90% 31.50%
Dizziness 200 8.50% 19% 27.50%
Stretch Marks 193 7.80% 10.90% 18.70%
Greasy Skin Acne 199 7.50% 18.60% 26.10%
Restless Legs 208 7.20% 23.10% 30.30%
Dry Mouth 210 7.10% 25.70% 32.80%
Breast Pain 173 6.50% 25.50% 32.00%
Altered Body Image 190 6.30% 19.50% 25.80%
Vomiting 210 6.20% 11.40% 17.60%
Sore Nipples 199 6.00% 23.60% 29.60%
Shortness of Breath 201 5.00% 25.90% 30.90%
Itch 198 4.50% 17.70% 22.20%
Snoring 207 4.30% 10.60% 14.90%
Varicose Veins 194 4.10% 12.90% 17.00%
Incontinence 209 3.80% 12.40% 16.20%
Carpel Tunnel 208 3.40% 7.70% 11.10%
Sciatica 209 3.30% 14.40% 17.70%
Anxiety 200 3.00% 16.50% 19.50%
Chloasma 201 3.00% 3.00% 6.00%
Thrush 203 2.50% 6.40% 8.90%
Painful Vein in Vagina 204 2.50% 2.90% 5.40%
Haemorrhoids 203 1.50% 4.40% 5.90%
Feeling Depressed 201 1.50% 20.40% 21.90%
Heart Palpitations 197 1.00% 9.10% 10.10%
Fainting 198 0.00% 2.50% 2.50%
As the number of women responding to questions varied, the denominator is displayed for each symptom (N).
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Table 2 Prevalence of self-reported limitations to activities of daily living
Frequency N Limit a lot Limit a little Total prevalence
Back pain 173 11.00% 41% 52.00%
Tiredness 173 9.20% 67.30% 76.30%
Poor Sleep 176 8.50% 46% 54.50%
Nausea 186 7% 23.10% 30.10%
Headache 167 6.60% 44.30% 50.90%
Hip Pelvic Pain 199 6.30% 22.20% 28.50%
Vomiting 194 5.20% 13.90% 19.10%
Forgetfulness 168 4.80% 29.80% 34.60%
Sciatica 195 4.10% 9.30% 13.40%
Urinary Frequency 173 2.90% 36.40% 39.30%
Change in Libido 175 2.90% 14.90% 17.80%
Altered body image 172 2.30% 8.10% 10.40%
SOB 177 2.30% 23.20% 25.50%
Dizziness 177 1.70% 26.20% 28.30%
Stretch Marks 174 1.70% 2.30% 4.00%
Food Cravings 183 1.60% 3.30% 4.90%
Leg Cramps 183 1.60% 15.30% 16.90%
Restless Legs 184 1.60% 12% 13.60%
Incontinence 194 1.50% 6.70% 8.20%
Change in Nipples 171 1.20% 4.70% 5.90%
Constipation 185 1.10% 10.30% 11.40%
Reflux 186 1.10% 14% 15.10%
Thrush 194 1.00% 3.10% 4.10%
Painful vein in Vag 200 1.00% 2.50% 3.50%
Vaginal Discharge 173 0.60% 6.90% 7.50%
Taste Smell changes 178 0.60% 15.20% 15.80%
Breast Pain 174 0.60% 8.00% 8.60%
Anxiety 200 0.60% 12.20% 12.80%
Feeling Depressed 175 0.60% 15.40% 16.00%
Greasy skin acne 182 0.50% 4.90% 5.40%
Dry Mouth 189 0.50% 2.60% 3.10%
Itch 183 0.50% 4.40% 4.90%
Snoring 188 0.50% 1.60% 2.10%
Varicose veins 183 0.50% 4.40% 4.90%
Carpel tunnel 204 0.50% 4.40% 4.90%
Vivid dreams 175 0.00% 4.60% 4.60%
Sore Nipples 174 0.00% 8.20% 8.20%
Chloasma 190 0.00% 0.50% 0.50%
Haemorrhoids 199 0.00% 1.00% 1.00%
Heart Palpitations 190 0.00% 6.30% 6.30%
Fainting 190 0.00% 2.10% 2.10%
As the number of women responding to questions varied, the denominator is displayed for each symptom (N). Women who did not experience a symptom did
not answer limit question.
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will be useful for other researchers who require an out-
come measure of pregnancy symptoms to assess the im-
pact of lifestyle or other pregnancy interventions.
Our research suggests that the PSI might also have a
role in clinical practice. We identified that when mid-
wives were prompted by this tool, they undertook add-
itional clinical assessment, which initiated referral to a
range of health care providers. This resulted in add-
itional care from physiotherapists, continence nurses
and mental health professionals. These referrals may
have been beneficial to the women, although our re-
search was not designed to assess any improvement in
women’s symptoms following such referrals. We believe
the non threatening nature of our PSI may be particu-
larly valuable in identifying women with issues that may
be particularly sensitive or difficult to discuss, such as
urinary incontinence. It has been estimated that total an-
nual cost of urinary incontinence in women from the
United States is around $12.4 billion [15]. Consequently,
early identification of incontinence may lead to cost
savings in this area. There is strong evidence that pelvic
floor exercises performed during and after pregnancy
can prevent urinary incontinence. One Australian study
that investigated over 30,000 women in differing age
groups found that one in three mid-age and older
women experience leaking urine and that it was signifi-
cantly associated with parity. This study suggested, as
less than half of these women had sought help, that this
issue should be brought up during their antenatal care
[16]. Available evidence indicates, because incontinence
is a somewhat embarrassing subject socially, that
patients and medical practitioners alike are reticent
about discussing it [17]. The PSI could be used to flag
such problems; patients who are uncomfortable bringing
up the topic may find it easier to “tick a box”, to alert
their midwife or doctor that they are experiencing
problems. Further, since the PSI has been designed
to be used at various time points, it may be helpful
in the early detection and treatment of pregnancy
symptoms, which in turn may reduce absenteeism via
early medical intervention. This is an area that would
require further study.
Our PSI was developed in Australia, in a multicultural,
English speaking cohort, and so it may not be
transferrable to other populations. Further testing of the
usefulness of the inventory in larger populations and in
different settings is required to test the external validity
of the instrument. It would also be useful to test the ef-
fectiveness of the PSI using a randomised control trial,
to assess outcomes such as: frequency of symptom-
related referrals; details of pathology tests ordered;
information about other requested tests, such as X-rays
and satisfaction with the prenatal booking in visit.Information about how to manage symptoms would also
be a useful addition to the PSI.
While our process of PSI development was robust, the
initial version missed the important symptom of swollen
hands and feet. Once this was identified, all experts
involved in the study agreed that this particular symp-
tom should be included.
While we included focus groups with women from the
first trimester, none of the participants who filled out
our survey were in the first trimester. Therefore, any fu-
ture research on the PSI should include women in their
first trimester.
Conclusion
In summary, we have developed a Pregnancy Symptoms
Inventory that should be very useful in the research set-
ting, and, subject to further research, may be a useful cli-
nical tool.
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